GEMC-511687728257997
Awarded to MANKIND PHARMA LIMITED
₹21,200
Products
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| VOMIKIND Ondansetron Tablet 4 mg | VOMIKIND / ONDANSETRON ORALLY DISINTEGRATING TABLET | 30049035 | 20,000 tablet(s) | 1.06 | 21,200 |
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹21,200Qualified 208 PHASE 3 OKHLA INDUSTRIAL ESTATE NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | L1 | Qualified |
Tender Value
₹21,200
EMD Value
Exempted
Closing Date
16 Sept 2024, 6:00 pmClosed
Ondansetron Tablet (Q2)
6873469
GEM/2024/B/5371413
Two Packet Bid
Ondansetron Tablet
GeM Contract
249403, General stores, Main Hospital BHEL Ranipur, Haridwar Uttarakhand Pin 249403 Quantit y Delivery to start after Delivery to be completed by __________
Total value wise evaluation
PRODUCT
Awarded to MANKIND PHARMA LIMITED
₹21,200
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| VOMIKIND Ondansetron Tablet 4 mg | VOMIKIND / ONDANSETRON ORALLY DISINTEGRATING TABLET | 30049035 | 20,000 tablet(s) | 1.06 | 21,200 |
1 document required · 1 mandatory
Exempted
3 Jan 2025
6 Sept 2024
16 Sept 2024
VOMIKIND Ondansetron Tablet 4 mg | Brand:VOMIKIND | Model:ONDANSETRON ORALLY DISINTEGRATING TABLET | HSN:30049035 | Qty:20,000 tablet(s) | UnitPrice:1.06 | Amount:21,200
contract_GEMC-511687728257997.pdf
GEM_CONTRACT • 0.11 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6873469.pdf
GEM_BID
guidelines-suspension-business-dealings-supplierscontractors.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .